P0547THE DELETION OF AKT1 ATTENUATES RENAL FIBROSIS AND TUBULAR EPITHELIAL-MESENCHYMAL TRANSITION DURING ACUTE KIDNEY INJURY TO CHRONIC KIDNEY DISEASE PROGRESSION

作者
Byung Min Ye,Il Young Kim,Min Jeong Kim,Soo Bong Lee,Dong Won Lee,Sang Heon Song,Eun Young Seong
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:35 (Supplement_3)
标识
DOI:10.1093/ndt/gfaa142.p0547
摘要

Abstract Background and Aims Acute kidney injury (AKI) is an underestimated, yet important risk factor for the development of chronic kidney disease (CKD), which is characterized by the tubulointerstitial fibrosis and tubular epithelial-mesenchymal transition (EMT). Akt has been reported to be involved in renal fibrosis and EMT. Thus, we investigated the role of Akt1, one of the three Akt isoforms, in the murine model of AKI to CKD progression. Method We subjected the wild type and Akt1−/− mice to unilateral ischemia-reperfusion injury (UIRI). UIRI was induced by clamping the left renal artery for 30 min followed by reperfusion. After 6 weeks of UIRI, the renal fibrosis and EMT were assessed by histology, immunohistochemistry, and western blot. Results After 6 weeks after UIRI, we found that Akt1, not Akt2 or Akt3, was activated in UIRI-kidney. The tubulointerstitial fibrosis was significantly alleviated in Akt1−/− mice compared with the wild type (WT) mice. Besides, the deletion of Akt1 decreased the expression of the vimentin and α-SMA and increased the expression of E-cadherin, indicating the suppression of tubular EMT. However, there was no difference in the activity of TGF-β1/Smad signalling, which is the potent inducer of renal fibrosis and EMT, between WT mice and Akt1−/− mice. The deletion of Akt1 also increased the GSK-3β activity and decreased the expression of β-catenin, Snail, and twist1. Conclusion Our findings demonstrate that the deletion of Akt1 attenuates the renal fibrosis and tubular EMT independently of TGF-β1/Smad signalling during the AKI to CKD progression. Akt1 may be the therapeutic target against the AKI to CKD progression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kvvcp完成签到,获得积分10
刚刚
阿椿发布了新的文献求助10
刚刚
mcl完成签到,获得积分10
1秒前
研友_VZG7GZ的应助被HuHengyi采纳,获得30
1秒前
2Y_DADA完成签到,获得积分10
1秒前
万能图书馆的应助被Ying采纳,获得10
1秒前
顽石完成签到,获得积分10
2秒前
不贪玩的不艳完成签到,获得积分10
2秒前
Parrot_PAI完成签到,获得积分10
2秒前
夏渃浠完成签到,获得积分10
2秒前
Carrie完成签到,获得积分10
2秒前
幸福来敲门完成签到,获得积分10
3秒前
孤星完成签到,获得积分10
3秒前
核桃发布了新的文献求助10
3秒前
棉花糖骆驼完成签到,获得积分10
3秒前
抗体小王完成签到,获得积分10
3秒前
莫愁完成签到,获得积分10
3秒前
神经娃完成签到,获得积分10
3秒前
mugen完成签到 ,获得积分10
3秒前
开放芝麻完成签到 ,获得积分10
4秒前
阿木的应助被dde采纳,获得10
4秒前
秋风的应助被HermanCheney采纳,获得30
4秒前
rtf发布了新的文献求助10
4秒前
科研中完成签到,获得积分10
4秒前
的法国队发布了新的文献求助10
4秒前
知识进脑子吧完成签到 ,获得积分10
5秒前
马俊完成签到,获得积分10
5秒前
多情无敌完成签到,获得积分10
6秒前
科研通AI6.2的应助被彭于晏采纳,获得10
6秒前
yurunxintian完成签到,获得积分10
6秒前
小明同学完成签到,获得积分10
6秒前
一休完成签到 ,获得积分10
6秒前
茯苓合道完成签到,获得积分10
7秒前
7秒前
谨慎问玉完成签到 ,获得积分10
7秒前
小岚花完成签到 ,获得积分10
7秒前
781473059完成签到,获得积分10
8秒前
飞翔完成签到,获得积分10
8秒前
爱柠完成签到,获得积分10
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159288
求助须知:如何正确求助?哪些是违规求助? 9554702
关于积分的说明 21720900
捐赠科研通 7748911
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552111
邀请新用户注册赠送积分活动 2471479